No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Altamira Therapeutics Receives Letter From Nasdaq Qualifications Department That It Is No Longer In Compliance
Express News | Altamira Therapeutics: Got on Sept 30, a Letter From Nasdaq That It No Longer Complied With Rule 5550(a)(2) of Nasdaq's Listing Rules
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
Earnings Call: Altamira Therapeutics Focuses on RNA Delivery Growth
Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript Summary
No Data
No Data